WellSync's BoomRx Achieves Milestone with Over $70 Million in Annualized Run Rate

WellSync and the Rise of BoomRx

In an impressive showcase of growth within the digital healthcare sector, WellSync has revealed that its subsidiary BoomRx is achieving remarkable success, surpassing an annualized run rate of over $70 million. Launched in July 2025, BoomRx has rapidly established itself as a pivotal player in pharmaceutical technology, streamlining prescription sourcing and fulfillment in a landscape that is increasingly reliant on telemedicine.

The Emergence of BoomRx

As telehealth continues to grow, with projections to leap from approximately $219 billion in 2026 to over $1.2 trillion by 2034, BoomRx has emerged as a cornerstone of WellSync's virtual care offerings. The platform, functioning as a pharmacy-infrastructure solution, addresses critical operational challenges faced by healthcare providers across the nation.

According to WellSync's CEO, Fabian Calvo, the impetus for BoomRx’s creation was the pressing need for a unified solution that could alleviate administrative burdens associated with prescription management. By investing heavily in the necessary technology and customer support systems, WellSync has positioned BoomRx to meet this demand head-on.

Addressing Key Pain Points

BoomRx’s centralized access model is designed not only to enhance operational efficiency but also to ensure compliance and reliable patient care experiences. Medical clinics utilizing BoomRx have reported significant improvements in managing and fulfilling prescriptions, with the platform now serving over 4,500 clinics nationwide and processing more than 40,000 orders monthly. These numbers reflect a robust 20% month-over-month growth rate, with over 85% of clinics choosing to reorder through this streamlined system.

Kurt Lunkwitz, co-founder and president of BoomRx, highlights that every enhancement made to the platform aims to assist medical clinics in operating more proficiently, all while strengthening compliance and patient care. Recent improvements have boosted pharmacy production capacity, expedited order fulfillment, improved safeguards against compliance issues, and simplified the onboarding process for new clients.

A Vision for the Future

The strategic developments underpinning BoomRx are clearly designed to reduce exposure to challenges common in the pharmaceutical distribution sector. This includes concerns over counterfeit medications, inaccurate interstate shipments, and improper handling of sensitive products. Lunkwitz emphasizes that by tackling these persistent issues, BoomRx not only supports clinics but also enhances overall patient satisfaction.

As BoomRx continues to grow, it stands as evidence of WellSync’s commitment to redefining healthcare delivery through innovative digital solutions. Whether it’s through improved operational practices or direct support for telehealth providers, BoomRx is proving essential to modern healthcare, reflecting broader trends and demands of the industry.

About WellSync

WellSync is leading the charge in healthcare innovation, creating a digital-first platform that connects healthcare providers and patients in transformative ways. Integrating clinical and medication fulfillment services into cohesive online solutions, WellSync is reshaping patient access while facilitating new revenue opportunities for healthcare practices.

With ongoing advancements and a focus on adaptability, WellSync is not just participating in the evolution of healthcare; the company is set to revolutionize how digital health partnerships function.

Visit wellsync.com for further details.

About BoomRx

Similar to WellSync's offerings, BoomRx operates as a comprehensive national pharmaceutical technology platform that simplifies ordering processes for regulatory-compliant products. By streamlining workflows and enhancing shipping and pricing transparency, BoomRx is transforming the operational capabilities of medical, wellness, and telemedicine practices, setting the stage for unprecedented growth within the industry. Learn more by connecting with BoomRx on LinkedIn or visiting boomrx.com.